Repository logo
 

Repurposing Drugs in Small Animal Oncology.

Published version
Peer-reviewed

Type

Article

Change log

Authors

Vieira, Rafael AM 
Hume, Kelly R 
Dobson, Jane 

Abstract

Repurposing drugs in oncology consists of using off-label drugs that are licensed for various non-oncological medical conditions to treat cancer. Repurposing drugs has the advantage of using drugs that are already commercialized, with known mechanisms of action, proven safety profiles, and known toxicology, pharmacokinetics and pharmacodynamics, and posology. These drugs are usually cheaper than new anti-cancer drugs and thus more affordable, even in low-income countries. The interest in repurposed anti-cancer drugs has led to numerous in vivo and in vitro studies, with some promising results. Some randomized clinical trials have also been performed in humans, with certain drugs showing some degree of clinical efficacy, but the true clinical benefit for most of these drugs remains unknown. Repurposing drugs in veterinary oncology is a very new concept and only a few studies have been published so far. In this review, we summarize both the benefits and challenges of using repurposed anti-cancer drugs; we report and discuss the most relevant studies that have been previously published in small animal oncology, and we suggest potential drugs that could be clinically investigated for anti-cancer treatment in dogs and cats.

Description

Keywords

oncology, repurposing drugs, small animal oncology

Journal Title

Animals (Basel)

Conference Name

Journal ISSN

2076-2615
2076-2615

Volume Title

13

Publisher

MDPI AG